These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 31956375)
1. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method. Ma B; Geng Y; Meng F; Yan G; Song F J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375 [No Abstract] [Full Text] [Related]
2. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
3. A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X PeerJ; 2020; 8():e10008. PubMed ID: 33024640 [TBL] [Abstract][Full Text] [Related]
4. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089 [TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma. Mi K; Zeng L; Chen Y; Yang S Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
7. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods. Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830 [TBL] [Abstract][Full Text] [Related]
8. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. He J; Li W; Li Y; Liu G Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717 [TBL] [Abstract][Full Text] [Related]
9. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma. Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y Front Genet; 2022; 13():833797. PubMed ID: 35154287 [No Abstract] [Full Text] [Related]
10. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related]
11. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning. Wang Q; Sun N; Zhang M Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475 [TBL] [Abstract][Full Text] [Related]
13. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm. Xu S; Zhou J; Liu K; Chen Z; He Z Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985 [TBL] [Abstract][Full Text] [Related]
14. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Li X; Li B; Ran P; Wang L Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance. Zhou E; Wu F; Guo M; Yin Z; Li Y; Li M; Xia H; Deng J; Yang G; Jin Y Front Oncol; 2022; 12():1008283. PubMed ID: 36530971 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies. Xue L; Bi G; Zhan C; Zhang Y; Yuan Y; Fan H Front Oncol; 2020; 10():835. PubMed ID: 32537435 [No Abstract] [Full Text] [Related]
17. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis. Zhang S; Zeng X; Lin S; Liang M; Huang H J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053 [TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma. Wu M; Wu Z; Yan J; Zeng J; Kuang J; Zhong C; Zhu X; Mo Y; Guo Q; Li D; Tan J; Zhang T; Zhang J Front Oncol; 2023; 13():1198746. PubMed ID: 37427142 [TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449 [TBL] [Abstract][Full Text] [Related]
20. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD). Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]